Nonetheless, our results clearly demonstrate that hemizygous congenital LDHB deficiency occurs among ALS patients, which encouraged us to employ ALS mouse models to test the hypothesis that LDHB deficiency can contribute to ALS-relevant pathology. This evidence concerns the gene LDHB and amyotrophic lateral sclerosis.